The impending decision by the Drug Enforcement Administration (DEA) to reclassify cannabis as a less dangerous controlled substance marks a significant shift in federal drug policy. Reliable reports confirming the DEA’s intent to move cannabis from a Schedule I drug — the strictest category of controlled substances — to Schedule III all but assure this outcome. The implications are profound, bringing obvious benefits but also potential drawbacks that may be consequential enough to require congressional action. First, drugs currently in Schedule I are those deemed to have no “medically accepted uses” and a high potential for abuse. A move to Schedule III serves as a recognition of cann
Hence then, the article about the prospects and perils of reclassifying cannabis as a less dangerous controlled substance was published today ( ) and is available onThe Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( The prospects and perils of reclassifying cannabis as a less dangerous controlled substance )